Notably, the super-enhancer linked to CD47 has been annotated before in breast cancer [59] and we show evidence of the increased activity of the constituent enhancers specifically within the cancer-epithelial cell types (Supplemental Figure S3). This evidence concerns the gene CD47 and breast cancer.